Details

Portfolio

Advancing Portfolio

Screening Program

Project Completed

RFP Year
2014
Awarded Amount
$137,883
Disease
Malaria
Intervention
Drug
Development Stage
Hit Identification
Collaboration Partners
Sumitomo Dainippon Pharma Co., Ltd., Medicines for Malaria Venture (MMV)